New findings and methods for feed engineering to face present and future challenges in salmon aquaculture Presenter Albert Caballero Solares PhD Collaborators X Xue 1 JR Hall 2 ID: 749319
Download Presentation The PPT/PDF document "Biomarker Platform for Commercial Aquacu..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Biomarker Platform for Commercial Aquaculture Feed Development project: New findings and methods for feed engineering to face present and future challenges in salmon aquaculture
Presenter:Albert Caballero Solares, Ph.DCollaborators:X. Xue1, J.R. Hall2, K. Eslamloo1, N.C. Smith1, S.M. Inkpen1, T. Katan1, J. Santander1, C.C. Parrish1, R.G. Taylor2 and M.L. Rise11Department of Ocean Sciences, Memorial University of Newfoundland, 1 Marine Lab Road, St. John's, NL A1C 5S7, Canada. 2Cargill Innovation, 4335 Dirdal, NorwaySlide2
Biomarker Platform for Commercial Aquaculture Feed Development projecta Genomic Applications Partnership Program (GAPP)
Funded by the Government of Canada through Genome Canada and Genome AtlanticTeam:Slide3
GAPP Biomarker Project: Experimental WorkflowSlide4
GAPP Biomarker Project: Experiments conducted
Feeding trial I(Raw materials)Feeding trial II(ω3/ω6 ratios)Nutrition
Immunity
HK RNA
Fish injected with PBS, poly(I:C)
qPCR
Macrophage RNA
Treated with PBS, poly(I:C)
Microarray/qPCR/Lipid composition
Hepatocytes RNA
Treated
tBHP
Microarray
qPCR
Liver RNA
(FM/FO
)
Microarray
qPCR
Lipid composition
Liver RNA
(EPA+DHA)
Microarray
qPCR
Lipid composition
Liver RNA
(
ω3/ω6
ratios
)
Microarray
qPCR
Lipid composition
HK RNA
Fish injected with PBS, poly(I:C), ASAL antigen
qPCR
Macrophage RNA
Treated with PBS, poly(I:C), LPS
Microarray/qPCR/Lipid composition
Feeding trial III
(
ISAv
challenge)Raw materialsFFI supplement
HK RNAISAv-exposed salmon (cohabitation)MicroarrayqPCR
Feeding trial IV
(SRS challenge)
No dietary component
HK RNASRS-exposed salmon (IP-injection)MicroarrayqPCR
In vitro FFI testing
Antioxidants
Primary HK macrophage cultures
Primary hepatocyte cultures
Immunostimulants
Primary HK macrophage culturesSlide5
GAPP Biomarker Project: Feeding trial ISlide6
GAPP Biomarker Project: Feeding trial I (2015)
Diet 1MARFO VOFM ABP VEG
Diet 2
Med-MAR
FM
ABP
VEG
FO
VO
Diet 3
ABP
FO
VO
FM
ABP
VEG
Diet 4
VEG
FM
ABP
VEG
FO
VO
Diet 5
ω
3LC0
FM
ABP
VEG
VO
Diet 6
ω
3LC1
FM ABP VEG
FO
VO
Diet 7
ω3LC1.4FM ABP VEG
FO
VO
+ Lipid and fatty acid composition
L
iver transcriptome
Agilent 44K salmonid oligonucleotide microarray
H
epatocyte response to oxidative stressAgilent 44K salmonid oligonucleotide microarray
Antiviral immune response
(head kidney)
R
eal-time
quantitative polymerase chain reaction
Effects of FM/FO replacement on Slide7
GAPP Biomarker Project: FM/FO replacement on liver transcriptome
Diet 1MAR
FO VO
FM
ABP VEG
Diet 2
Med-MAR
FM
ABP
VEG
FO
VO
Diet 3
ABP
FO
VO
FM
ABP
VEG
Diet 4
VEG
FM
ABP
VEG
FO
VO
Diet 5
ω3LC0FM ABP
VEGVODiet 6ω3LC1FM ABP
VEG
FO VO
Diet 7ω3LC1.4FM ABP VEG
FO
VOABP: down-regulated glycolysis correlated with feed intake (p<0.05) and
growth (p<0.05)VO-diets (ABP, VEG): up-regulated cholesterol synthesisVO-diets (ABP, VEG): up-regulated FA mobilization for β-oxidation
cholesterol synthesis found
inversely correlated to saturated FA in liver
(Manuscript in prep.)Slide8
GAPP Biomarker Project: FM/FO replacement on liver transcriptome
Diet-responsive antiviral transcriptsHigher constitutive levels in the liver of salmon fed VEG diet
Diet 1
MAR
FO
VO
FM
ABP
VEG
Diet 2
Med-MAR
FM
ABP
VEG
FO
VO
Diet 3
ABP
FO
VO
FM
ABP
VEG
Diet 4
VEG
FM
ABP VEGFO
VODiet 5ω3LC0FM ABP VEG
VO
Diet 6ω3LC1FM
ABP VEGFO VO
Diet 7
ω
3LC1.4FM ABP VEGFO
VO(Manuscript in prep.)Slide9
GAPP Biomarker Project: FM/FO replacement on HK transcriptome
Head kidney: diet-responsive antiviral transcriptsStronger poly(I:C) induction in the head kidney of salmon fed VEG dietSlide10
GAPP Biomarker Project: Feeding trial I (2015)
Diet 1MARFO VOFM ABP VEG
Diet 2
Med-MAR
FM
ABP
VEG
FO
VO
Diet 3
ABP
FO
VO
FM
ABP
VEG
Diet 4
VEG
FM
ABP
VEG
FO
VO
Diet 5
ω
3LC0
FM
ABP
VEG
VO
Diet 6
ω
3LC1
FM ABP VEG
FO
VO
Diet 7
ω3LC1.4FM ABP VEG
FO
VO
Antiviral immune response (macrophages)
Agilent 44K salmonid oligonucleotide microarray
L
iver transcriptome
Agilent 44K salmonid oligonucleotide microarray
Effects of EPA+DHA levels on+ Lipid and fatty acid composition Slide11
GAPP Biomarker Project: EPA+DHA levels on liver transcriptome
dietary EPA and DHA
desaturases
Diet 1
Marine
FO
VO
FM
ABP
VEG
Diet 2
Med-MAR
FM
ABP
VEG
FO
VO
Diet 3
ABP
FO
VO
FM
ABP
VEG
Diet 4
VEG
FM ABP VEGFO VO
Diet 5
ω3LC0FM ABP VEG
VODiet 6ω3LC1
FM
ABP VEGFO
VODiet 7ω3LC1.4FM ABP VEG
FO VO
Figures from Xi Xue (in prep.)Slide12
GAPP Biomarker Project: EPA+DHA levels on liver transcriptome
dietary EPA and DHA
interferon pathway.
Diet 1
Marine
FO
VO
FM
ABP
VEG
Diet 2
Med-MAR
FM
ABP
VEG
FO
VO
Diet 3
ABP
FO
VO
FM
ABP
VEG
Diet 4
VEG
FM ABP VEGFO VO
Diet 5
ω3LC0FM ABP
VEGVODiet 6ω3LC1
FM
ABP VEG
FO VODiet 7ω3LC1.4FM ABP VEG
FO VO
Figures from Xi
Xue
(in prep.)Slide13
GAPP Biomarker Project: Feeding trial II (2016)
Diet 1High ω3ω3:ω63:1
Diet
2Med ω
3
ω
3:
ω
6
2
:1
Diet 3
Balanced
ω
3:
ω
6
1
:1
Diet 4
Med
ω
6
ω
3:
ω
6
1:2
Diet 4
High
ω
6
ω
3:
ω
6
1:3
L
iver transcriptome
Agilent 44K salmonid oligonucleotide microarray
Antiviral immune response (head kidney)
R
eal-time quantitative polymerase chain reactionEffects of ω3/ω6 levels on Antiviral immune response (macrophages)Agilent 44K salmonid oligonucleotide microarraySlide14
GAPP Biomarker Project: effects of ω3/ω6 levels on
Figures from Tomer Katan (in prep.)Muscle FA compositionSlide15
GAPP Biomarker Project: effects of ω3/ω6 levels on
Figures from Tomer Katan (in prep.)Liver transcriptome: 44K microarray experimentCommon Reference(equal contribution of RNA from each individual)
2
2
2
2
2
2
2
2
High
ω
3 diet
High
ω
6 diet
Serine protease HTRA1 precursor
:
cell proliferation and apoptosis.
Integrin beta-5 precursor
:
immune function.
Peroxisomal proliferator-activated receptor A-interacting complex 285
kDa
protein
:
responsive to virus and
pIC
Cytochrome c oxidase subunit 1 and 2
:
mitochondrial respiratory chain complex.
Preliminary data:
Diet 1
High
ω
3
ω
3:
ω
6
3:1
Diet 2Med ω3
ω
3:ω
62:1
Diet 3Balanced
ω3:ω
61:1
Diet 4
Med ω6
ω
3:
ω6
1:2
Diet 4
High
ω
6
ω
3:
ω
6
1:3Slide16
GAPP Biomarker Project: effects of ω3/ω6 levels on
HK immune response to viral and bacterial PAMPsDiet 1High ω3ω3:ω6
3:1
Diet
2
Med
ω
3
ω
3:
ω
6
2
:1
Diet 3
Balanced
ω
3:
ω
6
1
:1
Diet 4
Med
ω
6
ω
3:
ω
6
1:2
Diet 4
High
ω
6
ω
3:
ω
6
1:3Slide17
GAPP Biomarker Project: effects of ω3/ω6 levels on
HK immune response
ω
6 FAs in diet
immune response
= ARA
levels across diets
but
(Manuscript in prep.)Slide18
GAPP Biomarker Project: effects of ω3/ω6 levels on
HK immune response
ω
6 FAs in diet
cathepsin
b
and
Lysozyme C-2
(Manuscript in prep.)Slide19
GAPP Biomarker Project: effects of ω3/ω6 levels on
HK inflammatory response
ω
6 FAs in diet:
pro-inflammatory
However, evidence of
fast recovery
(Manuscript in prep.)Slide20
GAPP Biomarker Project: Transcriptome & desired phenotypes
Diet-responsive genes related tonutritionDiet-responsive genes related toimmunityGrowth
Composition
(e.g. EPA &DHA)
Resistance to pathogensSlide21
GAPP Biomarker Project: Transcriptomic data obtainedSlide22
GAPP Biomarker Project: Selecting predictive gene biomarkers
gck, pfkfb5,6pgd,adssl1c,acac, idi1,
sqs,
dgat2a,
dgat2b,
fabp3a
,
fabp3b,
sgk2a
,
sgk2b
,
htra1a
,
htra1b
mxb
,
mxa
,
ifit5
mhcI
, lect2a, lect2b
igd
,
igma
,
igmb
, mtco1
Stepwise discriminant
analysis
(qPCR data of
25 transcripts)
Changes in relevant metabolic pathways
Changes in immune transcriptome
Included
DiscardedSlide23
Grouping variable
Biomarkers includedFunction% of varianceWilks' LambdaAccuracy (%)λ
χ2
df
p-value
Diet
sqs
,
gck
, sgk2b,
igd
1
79.5
0.116
57.1
8.0
<0.001
84
2
20.5
0.524
17.1
3.0
0.001
Growth (High, Low)
sgk2b, ifit5, mxb, htra1a
1
100
0.40224.6
4<0.00184
EPA+DHA (High, Low)
fabp3a, igd1
100
0.717
7.98
2
0.019
67
Results from discriminant analyses after categorizing individuals by
diet
,
growth
, and
muscle EPA+DHA levels
GAPP Biomarker Project: Predict desirable phenotypesSlide24
GAPP Biomarker Project: Multiplex platformsSlide25
GAPP Biomarker Project: Liver multiplexes
Liver multiplex I and II: primers for 48 gene biomarkersGenomeLab GeXPTM Analysis systemGood correlation of single and multiplex dataSlide26
GAPP Biomarker Project: Liver multiplexes
Validate previous findingsConfirm hypothesisExplore other pathwaysAnd,4. Generate predictive modelsSlide27
Results from discriminant analyses after categorizing individuals by diet, growth, and muscle EPA+DHA levels
GAPP Biomarker Project: Predict desirable phenotypesGrouping variableBiomarkers includedFunction
% of varianceWilks' Lambda
Accuracy (%)
λ
χ
2
df
p-value
Diet
pparb1,
apoaI
1
76.7
0.318
23.5
4.0
<0.001
73
2
23.3
0.722
6.7
1.0
0.010
Growth (High, Low)
pparb1,
igmb
, igfb5b1, pfkfb1, srebp2
1
100
0.866
27.1
5
<0.001
93
EPA+DHA (High, Low)
srebp1,
igmb
1
100
0.705
11.70
2
0.003
69
Slide28
GAPP Biomarker Project: ConclusionsSlide29
Thank you!